1. Cancer statistics, 2018;CA Cancer J Clin,2018
2. Real-world survival outcomes and prognostic factors among patients receiving first targeted therapy for advanced renal cell carcinoma: A SEER-Medicare database analysis;Clin Genitourin Cancer,2017
3. Disease-specific survival in de novo metastatic renal cell carcinoma in the cytokine and targeted therapy era;PLoS One,2013
4. Nivolumab versus everolimus in advanced renal-cell carcinoma;N Engl J Med,2015
5. Updated European association of urology guidelines on renal cell carcinoma: Immune checkpoint inhibition is the new backbone in first-line treatment of metastatic clear-cell renal cell carcinoma;Eur Urol,2019